Cancer patients could increase their chance of survival and help stop their cancer spreading by survival and help stop their cancer spreading by taking aspiring, new research suggests.
Cancer
patients
could
increase
their
chance
of
survival
and
help
stop
their
cancer
spreading
by
survival
and
help
stop
their
cancer
spreading
by
taking
aspiring
,
new
research
suggests
.
A daily pill was found to increase the chance of surviving cancer by 20 percent.
A
daily
pill
was
found
to
increase
the
chance
of
surviving
cancer
by
20
percent
.
Scientists at Cardiff University made the discovery after analysing a wealth of available date from studies of some cancers.
Scientists
at
Cardiff
University
made
the
discovery
after
analysing
a
wealth
of
available
date
from
studies
of
some
cancers
.
They found that patients who took low-dose aspirin in addition to their usual treatment reduced their likelihood of dying, or the cancer spreading, by one fifth over five years.
They
found
that
patients
who
took
low-dose
aspirin
in
addition
to
their
usual
treatment
reduced
their
likelihood
of
dying
,
or
the
cancer
spreading
,
by
one
fifth
over
five
years
.
"There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers," said Professor Peter Elwood, from the University of Cardiff, who led the research.
``
There
is
a
growing
body
of
evidence
that
taking
aspirin
is
of
significant
benefit
in
reducing
some
cancers
,
''
said
Professor
Peter
Elwood
,
from
the
University
of
Cardiff
,
who
led
the
research
.
"while we know a low dose of aspirin has been shown to reduce the possibility of catching cancer, its role in the treatment of cancer remains uncertain.
``
while
we
know
a
low
dose
of
aspirin
has
been
shown
to
reduce
the
possibility
of
catching
cancer
,
its
role
in
the
treatment
of
cancer
remains
uncertain
.
As a result, we set out to conduct a search of all the scientific literature."
As
a
result
,
we
set
out
to
conduct
a
search
of
all
the
scientific
literature
.
''
The team collected date from five trials and 42 studies.
The
team
collected
date
from
five
trials
and
42
studies
.
Although a known risk associated with taking aspirin regularly is bleeding in the gut, the researchers found no evidence of this being serious or life-threatening.
Although
a
known
risk
associated
with
taking
aspirin
regularly
is
bleeding
in
the
gut
,
the
researchers
found
no
evidence
of
this
being
serious
or
life-threatening
.
Researchers say the study highlights the need for trials to show if aspirin should be recommended alongside current cancer treatments.
Researchers
say
the
study
highlights
the
need
for
trials
to
show
if
aspirin
should
be
recommended
alongside
current
cancer
treatments
.
Professor Elwood added: "While there is a desperate need for more detailed research to prove our review and to obtain evidence on less common cancers, we'd urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low dose of aspirin as part of their cancer treatment."
Professor
Elwood
added
:
``
While
there
is
a
desperate
need
for
more
detailed
research
to
prove
our
review
and
to
obtain
evidence
on
less
common
cancers
,
we
'd
urge
patients
diagnosed
with
cancer
to
speak
to
their
doctor
about
our
findings
so
they
can
make
an
informed
decision
as
to
whether
or
not
they
should
take
a
low
dose
of
aspirin
as
part
of
their
cancer
treatment
.
''
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "This study adds significant weight to the idea that a drug as simple and cheap as aspirin could help treat breast and other cancers.
Baroness
Delyth
Morgan
,
Chief
Executive
at
Breast
Cancer
Now
,
said
:
``
This
study
adds
significant
weight
to
the
idea
that
a
drug
as
simple
and
cheap
as
aspirin
could
help
treat
breast
and
other
cancers
.
"Clinical trials are going on to confirm whether aspirin could be added to routine treatments for breast cancer.
``
Clinical
trials
are
going
on
to
confirm
whether
aspirin
could
be
added
to
routine
treatments
for
breast
cancer
.
Further research is needed to understand exactly which patients would benefit from aspirin and enable us to direct it to the most appropriate individuals."
Further
research
is
needed
to
understand
exactly
which
patients
would
benefit
from
aspirin
and
enable
us
to
direct
it
to
the
most
appropriate
individuals
.
''
Cancer patients could increase their chance of survival and help stop their cancer spreading by survival and help stop their cancer spreading by taking aspiring, new research suggests. A daily pill was found to increase the chance of surviving cancer by 20 percent.  Scientists at Cardiff University made the discovery after analysing a wealth of available date from studies of some cancers. They found that patients who took low-dose aspirin in addition to their usual treatment reduced their likelihood of dying, or the cancer spreading, by one fifth over five years.  "There is a growing body of evidence that taking aspirin is of significant benefit in reducing some cancers," said Professor Peter Elwood, from the University of Cardiff, who led the research. "while we know a low dose of aspirin has been shown to reduce the possibility of catching cancer, its role in the treatment of cancer remains uncertain. As a result, we set out to conduct a search of all the scientific literature."  The team collected date from five trials and 42 studies. Although a known risk associated with taking aspirin regularly is bleeding in the gut, the researchers found no evidence of this being serious or life-threatening. Researchers say the study highlights the need for trials to show if aspirin should be recommended alongside current cancer treatments.  Professor Elwood added: "While there is a desperate need for more detailed research to prove our review and to obtain evidence on less common cancers, we'd urge patients diagnosed with cancer to speak to their doctor about our findings so they can make an informed decision as to whether or not they should take a low dose of aspirin as part of their cancer treatment."  Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "This study adds significant weight to the idea that a drug as simple and cheap as aspirin could help treat breast and other cancers.  "Clinical trials are going on to confirm whether aspirin could be added to routine treatments for breast cancer. Further research is needed to understand exactly which patients would benefit from aspirin and enable us to direct it to the most appropriate individuals."